| abstract |
This application relates to compounds of formula (I): or a pharmaceutically acceptable salt or stereoisomer thereof, which modulates the activity of adenosine receptors such as subtype A2A and A2B receptors, and is useful in the treatment of diseases associated with the activity of adenosine receptors, including, for example, cancer, Inflammatory, cardiovascular and neurodegenerative diseases. |